Connor Clark & Lunn Investment Management Ltd. Sells 4,140 Shares of Chemed Co. (NYSE:CHE)

Connor Clark & Lunn Investment Management Ltd. trimmed its holdings in Chemed Co. (NYSE:CHE - Free Report) by 64.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,242 shares of the company's stock after selling 4,140 shares during the period. Connor Clark & Lunn Investment Management Ltd.'s holdings in Chemed were worth $1,188,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. State Street Corp boosted its holdings in shares of Chemed by 0.8% during the 3rd quarter. State Street Corp now owns 464,354 shares of the company's stock worth $279,063,000 after buying an additional 3,564 shares during the period. Geode Capital Management LLC boosted its holdings in Chemed by 4.9% during the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock valued at $201,820,000 after acquiring an additional 15,791 shares during the period. Boston Trust Walden Corp grew its position in shares of Chemed by 10.0% in the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock valued at $128,303,000 after purchasing an additional 22,105 shares during the last quarter. FMR LLC increased its stake in shares of Chemed by 23.8% in the third quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after purchasing an additional 45,917 shares during the period. Finally, Copeland Capital Management LLC lifted its position in shares of Chemed by 16.8% during the 4th quarter. Copeland Capital Management LLC now owns 151,623 shares of the company's stock worth $80,330,000 after purchasing an additional 21,834 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Remove Ads

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Brian C. Judkins bought 145 shares of Chemed stock in a transaction dated Monday, December 30th. The stock was purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. 3.32% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Royal Bank of Canada upped their price target on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday, March 14th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Chemed Trading Up 2.2 %

CHE stock traded up $12.82 during trading on Monday, reaching $606.93. 119,185 shares of the stock were exchanged, compared to its average volume of 89,104. The stock has a 50 day simple moving average of $567.72 and a 200-day simple moving average of $565.35. The company has a market capitalization of $8.88 billion, a P/E ratio of 30.67, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $648.29.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.33%. Chemed's dividend payout ratio (DPR) is currently 10.05%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.